Search
Close this search box.

Blog

Filters
Categories
Search

“What If Vasculitis Stops Me From Becoming a Mother?”

Blog Samantha SainteMarie was in graduate school, working to get her master’s degree in mental health counseling, when it first happened. She was typing a research paper and noticed that her legs and feet had swollen. By the time the swelling went down, purpura–purple patches on her skin–were all over. “It looked like a port […]

Top Vasculitis-Friendly Travel Tips for the Holidays

Blog Getting ready to travel? Our community of vasculitis warriors shared their top travel tips to help you face your adventures with extra calm and control! Got a long flight or car ride? Wear compression socks. And don’t forget to get up and move every hour. Elevate your legs to help with leg pain in […]

Painting Her Pain: How One Woman Uses Art to Tell Her Vasculitis Story

Blog When Dr. Shanali Perera chose to become a rheumatologist, specializing in vasculitis, she thought she’d chosen oneof the last specialties that looks at the entire body. “I thought I’d be like Sherlock Holmes,” she said, investigating the whole body, finding clues to her patients’ puzzles.She had no idea her curiosity for investigation would soon […]

12 Things I’m Grateful For Because of Vasculitis

Blog ‘Tis the season of thankfulness. Although life with vasculitis isn’t always easy, we wanted to know: how has this disease impacted you for the better? We reached out to our community and asked them: “Despite vasculitis, or because of it, what are you grateful for?” Here’s what some of you said: Without vasculitis, I […]

Amgen Successfully Completes Acquisition of ChemoCentryx

Blog TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active ANCA-Associated Vasculitis, Added to Inflammation Portfolio THOUSAND OAKS, Calif., (Oct. 20, 2022) – Amgen (NASDAQ: AMGN) today announced that it has successfully completed its previously announced acquisition of ChemoCentryx, Inc. (NASDAQ: CCXI), a biopharmaceutical company focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders […]

US FDA approves Regeneron-Sanofi’s Kevzara to treat polymyalgia rheumatica

Blog The US Food and Drug Administration (FDA) has granted approval for Regeneron Pharmaceuticals and Sanofi’s Kevzara (sarilumab) to treat polymyalgia rheumatica (PMR) in adult patients. Kevzara has been approved as the first and only biologic indicated for PMR adult patients who did not respond to corticosteroids or who cannot tolerate corticosteroid taper. Developed using […]